Literature DB >> 21264758

Elective palliative resection of incurable stage IV colorectal cancer: who really benefits from it?

Renato Costi1, Davide Di Mauro, Licia Veronesi, Andrea Ardizzoni, Pierfranco Salcuni, Luigi Roncoroni, Leopoldo Sarli, Vincenzo Violi.   

Abstract

PURPOSE: Despite the encouraging results of chemotherapy in patients affected by incurable colorectal cancer (CRC), surgical resection of a primitive tumor is still a common approach worldwide. The identification of prognostic factors related to short survival (<6 months) may allow excluding from resective surgery those who may not benefit from it.
METHODS: A retrospective analysis was performed of 15 variables in a population of 71 patients undergoing nonemergency palliative primary resections of incurable CRC, including patients' demographics and clinical/histopathological characteristics of the tumor.
RESULTS: No variables were related to perioperative mortality (8.5% overall). A multivariate analysis revealed that older age (≥80 years) and metastasis to more than 25% of the lymph nodes were associated with survival (4 and 6 months, respectively). Mucoid adenocarcinoma therefore tends to be associated with the prognosis (P = 0.070).
CONCLUSIONS: An elderly age tends to be a contraindication to an elective primary tumor resection in patients affected by incurable CRC. Massive lymph node involvement and mucoid adenocarcinoma should also be considered before planning major colonic surgery.

Entities:  

Mesh:

Year:  2011        PMID: 21264758     DOI: 10.1007/s00595-009-4253-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  41 in total

1.  How aggressive should we be in patients with stage IV colorectal cancer?

Authors:  Li-Jen Kuo; Shuh-Yan Leu; Mei-Ching Liu; James Jer-Min Jian; Skye Hongiun Cheng; Chung-Ming Chen
Journal:  Dis Colon Rectum       Date:  2003-12       Impact factor: 4.585

2.  Initial presentation with stage IV colorectal cancer: how aggressive should we be?

Authors:  S A Rosen; J F Buell; A Yoshida; S Kazsuba; R Hurst; F Michelassi; J M Millis; M C Posner
Journal:  Arch Surg       Date:  2000-05

3.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

4.  Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer.

Authors:  A I Sarela; J A Guthrie; M T Seymour; E Ride; P J Guillou; D S O'Riordain
Journal:  Br J Surg       Date:  2001-10       Impact factor: 6.939

5.  Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit.

Authors:  J Mella; A Biffin; A G Radcliffe; J D Stamatakis; R J Steele
Journal:  Br J Surg       Date:  1997-12       Impact factor: 6.939

6.  Eight years experience of high-powered endoscopic diode laser therapy for palliation of colorectal carcinoma.

Authors:  Edward D Courtney; Ashraf Raja; Roger J Leicester
Journal:  Dis Colon Rectum       Date:  2005-04       Impact factor: 4.585

7.  Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum.

Authors:  R Goslin; G Steele; N Zamcheck; R Mayer; J MacIntyre
Journal:  Dis Colon Rectum       Date:  1982 Nov-Dec       Impact factor: 4.585

8.  Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma.

Authors:  Tadahiro Nozoe; Emiko Mori; Ikuo Takahashi; Takahiro Ezaki
Journal:  Surg Today       Date:  2008-07-09       Impact factor: 2.549

9.  Indications and surgical alternatives for palliation of rectal cancer.

Authors:  Victor W Fazio
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

10.  Estimated median survival times of patients with colorectal cancer based on experience with 9,745 patients.

Authors:  D T Silverman; J L Murray; C R Smart; C C Brown; M H Myers
Journal:  Am J Surg       Date:  1977-03       Impact factor: 2.565

View more
  8 in total

Review 1.  Should noncurative resection of the primary tumour be performed in patients with stage iv colorectal cancer? A systematic review and meta-analysis.

Authors:  S Ahmed; R K Shahid; A Leis; K Haider; S Kanthan; B Reeder; P Pahwa
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

2.  Clinical features and prognostic factors of bone metastases from colorectal cancer.

Authors:  Sei-ichiro Jimi; Takaharu Yasui; Masayuki Hotokezaka; Kazuo Shimada; Yuji Shinagawa; Hiroshi Shiozaki; Nobuo Tsutsumi; Shigeaki Takeda
Journal:  Surg Today       Date:  2012-12-09       Impact factor: 2.549

Review 3.  Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review.

Authors:  Louis de Mestier; Gilles Manceau; Cindy Neuzillet; Jean Baptiste Bachet; Jean Philippe Spano; Reza Kianmanesh; Jean Christophe Vaillant; Olivier Bouché; Laurent Hannoun; Mehdi Karoui
Journal:  World J Gastrointest Oncol       Date:  2014-06-15

4.  Evaluation of the necessity of primary tumor resection for synchronous metastatic colorectal cancer.

Authors:  Yuji Miyamoto; Masayuki Watanabe; Yasuo Sakamoto; Hironobu Shigaki; Asuka Murata; Hidetaka Sugihara; Kojiro Etoh; Takatsugu Ishimoto; Masaaki Iwatsuki; Yoshifumi Baba; Shiro Iwagami; Naoya Yoshida; Hideo Baba
Journal:  Surg Today       Date:  2014-03-14       Impact factor: 2.549

Review 5.  Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist.

Authors:  Renato Costi; Francesco Leonardi; Daniele Zanoni; Vincenzo Violi; Luigi Roncoroni
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

6.  A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis.

Authors:  S R Dorajoo; W J H Tan; S X Koo; W S Tan; M H Chew; C L Tang; H L Wee; C W Yap
Journal:  Int J Colorectal Dis       Date:  2015-10-21       Impact factor: 2.571

7.  GRECCAR 8: impact on survival of the primary tumor resection in rectal cancer with unresectable synchronous metastasis: a randomized multicentre study.

Authors:  Eddy Cotte; Laurent Villeneuve; Guillaume Passot; Gilles Boschetti; Sylvie Bin-Dorel; Yves Francois; Olivier Glehen
Journal:  BMC Cancer       Date:  2015-02-12       Impact factor: 4.430

8.  Prognostic Impact of Tumor Status, Nodal Status and Tumor Sidedness in Metastatic Colon Cancer.

Authors:  Shiva Kumar R Mukkamalla; Ponnandai Somasundar; Bharti Rathore
Journal:  Cureus       Date:  2020-11-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.